Medical Devices Series B Investors & VC Firms
660 firms in this list, with a median first check of $730K. 140 of them lead rounds. Generated from verified public data and updated continuously.
Dimension Capital
San FranciscoSeed–Late Stage$1M – $10M
13 people
Quan Capital
ShanghaiSeed–Late Stage
16 people
Ajax Health
Menlo ParkSeed–Late Stage
23 people
Wasatch Equity Partners
LoganSeed–Late Stage$1M – $100M
12 people
Solas BioVentures
ChattanoogaPre-Seed–Series B
14 people
Tenmile
Seed–Growth
11 people
MaRS
TorontoPre-Seed–Late Stage
19 people
Mount Judi Ventures
BengaluruPre-Seed–Series B
18 people
Allumia Ventures
SeattleSeries A–Late Stage$5M – $15M
11 people
Thorney Investment Group
MelbourneSeed–Late Stage
23 people
IW Capital
LondonSeed–Growth
16 people
Scientia Ventures
New YorkSeries A–Series B
13 people
Delos Capital
CambridgeSeed–Late Stage
12 people
Asahi Kasei Corporate Venture Capital
Menlo ParkPre-Seed–Late Stage$500K – $3M
19 people
Vensana Capital
MinneapolisSeries A–Late Stage
13 people
Medical Excellence Capital
New YorkPre-Seed–Series B
17 people
AME Cloud Ventures
Palo AltoSeed–Late Stage$1M – $10M
10 people
V-Bio Ventures
GhentSeed–Growth$270K – $2.2M
13 people
Bioqube Ventures
BrusselsPre-Seed–Late Stage$108K – $6.5M
19 people
WELL Ventures
VancouverSeed–Growth
16 people
SCI Ventures
LondonSeed–Series B
18 people
Sonder Capital
San CarlosPre-Seed–Late Stage
15 people
LYFE Capital
Menlo ParkSeed–Late Stage
17 people
New Science Ventures
GreenwichSeed–Late Stage$2M – $8M
7 people
Related lists
Series B Investors & VC Firms (4094)Series B Investors & VC Firms in United States (1625)Medical Devices Investors & VC Firms (1393)SaaS Series B Investors & VC Firms (1317)Series B Investors & VC Firms in Global (1265)Enterprise Software Series B Investors & VC Firms (1242)Healthtech Series B Investors & VC Firms (1216)Medical Devices Seed Investors & VC Firms (1155)Medical Devices Series A Investors & VC Firms (1145)Fintech Series B Investors & VC Firms (1141)
Data sourced from public filings and firms' own websites — see our methodology.














































































